Literature DB >> 2447498

Levels of fetal hemoglobin necessary for treatment of sickle cell disease.

C T Noguchi1, G P Rodgers, G Serjeant, A N Schechter.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2447498     DOI： 10.1056/NEJM198801143180207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  54 in total

1.  Identification of Id2 as a globin regulatory protein by representational difference analysis of K562 cells induced to express gamma-globin with a fungal compound.

Authors:  M L Holmes; J D Haley; L Cerruti; W L Zhou; H Zogos; D E Smith; J M Cunningham; S M Jane
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

2.  SIRT1 activates the expression of fetal hemoglobin genes.

Authors:  Yan Dai; Tyngwei Chen; Heba Ijaz; Elizabeth H Cho; Martin H Steinberg
Journal:  Am J Hematol       Date:  2017-08-28       Impact factor: 10.047

Review 3.  Future prospects for treatment of hemoglobinopathies.

Authors:  J A Stamatoyannopoulos
Journal:  West J Med       Date:  1992-12

4.  Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers.

Authors:  Susan P Perrine; William A Wargin; Michael S Boosalis; Wayne J Wallis; Sally Case; Jeffrey R Keefer; Douglas V Faller; William C Welch; Ronald J Berenson
Journal:  J Clin Pharmacol       Date:  2011-03-21       Impact factor: 3.126

Review 5.  Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia.

Authors:  Anna Rita Migliaccio; Dante Rotili; Angela Nebbioso; George Atweh; Antonello Mai
Journal:  Int J Biochem Cell Biol       Date:  2008-05-29       Impact factor: 5.085

Review 6.  Hemoglobin research and the origins of molecular medicine.

Authors:  Alan N Schechter
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

7.  Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.

Authors:  W N Poillon; B C Kim; G P Rodgers; C T Noguchi; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

8.  Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.

Authors:  Orapan Sripichai; Christine M Kiefer; Natarajan V Bhanu; Toshihiko Tanno; Seung-Jae Noh; Sung-Ho Goh; J Eric Russell; Cheryl L Rognerud; Ching-Nan Ou; Patricia A Oneal; Emily R Meier; Nicole M Gantt; Colleen Byrnes; Y Terry Lee; Ann Dean; Jeffery L Miller
Journal:  Blood       Date:  2009-07-13       Impact factor: 22.113

9.  Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease.

Authors:  Eduard J van Beers; Leigh Samsel; Laurel Mendelsohn; Rehan Saiyed; Kleber Y Fertrin; Christine A Brantner; Mathew P Daniels; James Nichols; J Philip McCoy; Gregory J Kato
Journal:  Am J Hematol       Date:  2014-04-12       Impact factor: 10.047

Review 10.  Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies.

Authors:  S P Perrine; D V Faller
Journal:  Experientia       Date:  1993-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.